Calendar eFFECTOR Therapeutics, Inc. Deutsche Boerse AG
Stocks
LWK1
US28202V1089
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
11:59:01 24/06/2024 +04
|
5-day change | 1st Jan Change | ||
| 1.075 EUR | +0.47% |
|
-8.12% | -88.97% |
| 11/09/24 | Tyra Biosciences Names Doug Warner Chief Medical Officer | MT |
| 08/07/24 | EFFECTOR Therapeutics, Inc.(OTCPK:EFTR) dropped from S&P TMI Index | CI |
Upcoming events on eFFECTOR Therapeutics, Inc.
No events available
Past events on eFFECTOR Therapeutics, Inc.
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,43 1,21 18.01% | 3,55 3,55 0.04% | 0,00 0,00 - |
|
EBITDA Million USD | Released Forecast Spread | -31,9 -27,9 -14.36% | -32,4 -36,0 10.19% | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -31,9 -29,9 -6.56% | -32,4 -34,2 5.25% | -33,8 -32,2 -4.96% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 15,8 -11,0 243.44% | -22,7 -23,9 5.14% | -35,8 -34,2 -4.75% |
|
Net income Million USD | Released Forecast Spread | 15,8 -11,0 243.44% | -22,7 -23,8 4.83% | -35,8 -34,2 -4.77% |
|
EPS USD | Released Forecast Spread | 11,0 -10,2 208.37% | -13,8 -14,3 3.51% | -16,4 -15,6 -4.97% |
| Announcement Date | 16/03/22 | 08/03/23 | 26/03/24 |
Quarterly results
| Fiscal Period | March | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,87 0,64 35.05% | 0,67 0,66 1.51% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -9,25 -10,2 8.86% | -8,72 -10,5 16.98% | -9,54 -8,32 -14.66% | -7,86 -8,66 9.33% | -7,86 -7,73 -1.64% | -8,60 -7,02 -22.44% | -8,40 -8,53 1.52% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -9,56 -9,79 2.36% | -9,26 -9,58 3.33% | -10,0 -8,44 -18.7% | -8,36 -7,67 -9.05% | -8,30 -7,87 -5.56% | -9,13 -7,50 -21.78% | -8,83 -8,90 0.75% |
|
Net income Million USD | Released Forecast Spread | -9,56 -9,79 2.36% | -9,26 -9,58 3.33% | -10,0 -8,44 -18.7% | -8,36 -7,67 -9.05% | -8,30 -7,87 -5.56% | -9,13 -7,50 -21.78% | -8,83 -8,90 0.75% |
|
EPS USD | Released Forecast Spread | -5,75 -5,35 -7.48% | -5,50 -5,95 7.56% | -6,00 -3,38 -77.78% | -4,25 -4,94 13.92% | -3,25 -3,08 -5.41% | -3,42 -2,73 -25.27% | -2,16 -2,17 0.23% |
| Announcement Date | 07/11/22 | 08/03/23 | 09/05/23 | 08/08/23 | 13/11/23 | 26/03/24 | 09/05/24 |
| 22/09/2026 |  | Earnings presentation | 09:00 |
| 22/09/2026 | | Présentation aux Actionnaires / Analystes | 16:00 |
| 22/09/2026 | | Annual General Meeting | |
| 22/09/2026 | | Earnings release - Q2 2026 | |
| 22/09/2026 | | Earnings presentation | 16:00 |
| 23/09/2026 | | Earnings presentation | 11:30 |
| 23/09/2026 | | Board of Directors Meeting | |
| 23/09/2026 | | Earnings release - Q2 2026 | |
| 24/09/2026 | | Annual General Meeting | |
| 25/09/2026 | | Earnings presentation | 17:00 |
Past sector events for eFFECTOR Therapeutics, Inc.
| 18/09/2026 | | Information meeting | 00:30 |
| 17/09/2026 | | Extraordinary General Meeting | 17:00 |
| 17/09/2026 | | Extraordinary General Meeting | 11:00 |
| 17/09/2026 | | Présentation aux Actionnaires / Analystes | 06:00 |
| 17/09/2026 | | Extraordinary General Meeting | 06:00 |
| 16/09/2026 | | Earnings presentation | 11:00 |
| 16/09/2026 | | Earnings presentation | 11:00 |
| 16/09/2026 | | Earnings presentation | 11:00 |
| 16/09/2026 | | Earnings presentation | 11:00 |
| 16/09/2026 | | Earnings presentation | 11:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- EFTR Stock
- LWK1 Stock
- Calendar eFFECTOR Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
